Risk factors for cardiac events in carfilzomib-treated patients in the Marketscan database (20160186)

19/05/2016
30/03/2024
EU PAS number:
EUPAS13518
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol for Marketscan CVD Events MM _05022016_final

English (634.73 KB - PDF) View document
Study results
Study results

Abstract 20160186_Carfilzomib_31May2017

English (122.9 KB - PDF) View document
Study report
Other information